Target intelligence / Profile preview

Bacterial and fungal cell wall component (None in common use; scientific literature generally refers to individual components (e.g., peptidoglycan, chitin, glucan) rather than a combined abbreviation)

Target
None in common use; scientific literature generally refers to individual components (e.g., peptidoglycan, chitin, glucan) rather than a combined abbreviation
Molecular classification
Other (not a receptor, enzyme, transporter, etc.; composed of structural polysaccharides and glycoproteins), Polysaccharide matrix, Glycoprotein complex, Scaffold structure
01

Overview

Bacterial and fungal cell wall components comprise the structural exoskeletons surrounding microbial cells, crucial for the maintenance of cell shape, protection from environmental threats, and osmotic regulation. In bacteria, the cell wall is primarily composed of peptidoglycan, a macromolecular lattice unique to prokaryotes and the principal target of classic antibiotics such as β-lactams and glycopeptides. Fungal cell walls, by contrast, consist mainly of chitin, β-(1,3)-glucan and β-(1,6)-glucan, mannoproteins, and glycosylphosphatidylinositol (GPI)-anchored proteins. These components confer rigidity, mediate adhesion, contribute to immune evasion, and are unique to fungi, making them prime targets for antifungal drugs like echinocandins and investigational agents such as ibrexafungerp and nikkomycin Z. Both bacterial and fungal cell wall targets offer avenues for antimicrobial therapy and diagnostic biomarker development. However, cell wall plasticity and biosynthetic redundancy in these organisms can complicate treatment efficacy and drive drug resistance.

Other names
Bacterial cell wallFungal cell wallPeptidoglycan (bacteria-specific)Chitin, β-(1,3)-glucan, mannoproteins, GPI-anchored proteins (fungi-specific)
02

Mechanism of action

Inhibition of cell wall biosynthesis enzymes (β-glucan synthase, chitin synthase, transpeptidases) Disruption of cell wall integrity leading to cell lysis Inhibition of glycosylation or anchor biosynthesis pathways (GPI) Immune system targeting exposed components, exploiting unmaksed wall antigens

03

Biological functions

Structural support and rigidityProtection from environmental stressOsmotic regulationCell adhesion (via specific wall proteins)Immune evasion and recognition
04

Disease associations

Infection (bacterial, fungal)Drug resistanceInflammation (host immune response)Other (biofilm formation, virulence)
05

Safety considerations

Potential for off-target toxicity (especially with non-specific agents)Resistance development via compensatory wall biosynthesis/remodelingHypersensitivity reactions (e.g., β-lactam allergy)Some cell wall inhibitors (e.g., echinocandins) can trigger cell wall stress responses, leading to drug toleranceChallenge in selectively targeting fungal components without affecting human cells (note: humans lack these components, limiting intrinsic toxicity)
06

Interacting drugs

Antibacterials targeting peptidoglycan: β-lactams (penicillins, cephalosporins), glycopeptides (vancomycin)

2 more in the full profile.

07

Biomarkers

β-(1,3)-D-glucan (diagnostic for fungal infections, especially invasive)Anti-Bgl2 antibodies (potential biomarker for candidiasis)Mannan/mannoprotein antigen detection in serum (fungal)Peptidoglycan detection (bacterial sepsis)

Beyond the preview

Go deeper on Bacterial and fungal cell wall component (None in common use; scientific literature generally refers to individual components (e.g., peptidoglycan, chitin, glucan) rather than a combined abbreviation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and fungal cell wall component (None in common use; scientific literature generally refers to individual components (e.g., peptidoglycan, chitin, glucan) rather than a combined abbreviation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call